ClinicalTrials.Veeva

Menu

Irisin Expression and Gene Polymorphism With Peripartum Cardiomyopathy.

S

Sohag University

Status

Enrolling

Conditions

Peripartum Cardiomyopathy

Study type

Observational

Funder types

Other

Identifiers

NCT04927715
Soh-Med-21-02-26

Details and patient eligibility

About

this is an observertional study aimed at Study the association between the level of irisin expression and (Fibronectin Type III Domain Containing 5 (FDNC5) gene polymorphism in female patients with peripartum cardiomyopathy.

Enrollment

45 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • This study will include females aged between 18 and 45 years old who have been diagnosed and treated clinically for peripartum cardiomyopathy

Exclusion criteria

  • Age less than 18 or more than 45 year old
  • females with dilated cardiomyopathy due to other etiology or outside the time frame of occurrence of peripartum cardiomyopathy

Trial design

45 participants in 2 patient groups

Diseased
Description:
Females with peripartum cardiomyopathy
Control
Description:
Healthy females

Trial contacts and locations

1

Loading...

Central trial contact

Ali mo Altaher, lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems